TrialThe Journal of infectious diseases2025

In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA).

Marie-Angélique De Scheerder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.